Magentiq Eye - About the company
Magentiq Eye is a series A company based in Haifa (Israel), founded in 2015 by Yuval Chomski and Dror Zur. It operates as a Computer vision technology in endoscopic procedures. Magentiq Eye has raised $100K in funding from Neuron.VC and aMoon. The company has 957 active competitors, including 235 funded and 117 that have exited. Its top competitors include companies like Denali Therapeutics, Caris Life Sciences and Personalis.
Company Details
Magentiq Eye provides software based on computer vision and machine learning technology to provide assistance to doctors in performing medical procedures. Its current portfolio includes software that assist in detection of colon cancer through colonoscopy and endoscopy.
- Website
- magentiq.com
Key Metrics
Founded Year
2015
Location
Haifa, Israel
Stage
Series A
Total Funding
$100K in 4 rounds
Latest Funding Round
Ranked
54th among 957 active competitors
Employee Count
27 as on Apr 30, 2026
Similar Companies
Sign up to download Magentiq Eye's company profile
Magentiq Eye's funding and investors
Magentiq Eye has raised a total funding of $100K over 4 rounds. Its first funding round was on Jun 2016. Its latest funding round was a Series A round on Jul 30, 2025 for $*****. 6 investors participated in its latest round. Magentiq Eye has 10 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Magentiq Eye:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 30, 2025 | 5101766 | Series A | 9603004 | 5989102 | 2429643 | 8365549 |
Jul 31, 2019 | 9368673 | Grant (prize money) | 9951025 | 6392293 | 5358785 | |
Feb 01, 2019 | 4662641 | Grant (prize money) | 7860417 | 7535356 | 9702532 |
View details of Magentiq Eye's funding rounds and investors
Magentiq Eye's founders and board of directors
Founder? Claim ProfileThe founders of Magentiq Eye are Yuval Chomski and Dror Zur.
Here are the details of Magentiq Eye's key team members:
- Yuval Chomski: Co Founder, Investor of Magentiq Eye and founder of 3 other companies, Check Mate, Invertex and Moving Life.
- Dror Zur: Co-Founder & VP R&D of Magentiq Eye and founder of 1 other company. Contact Info: 2 email addresses
View details of Magentiq Eye's Founder profiles and Board Members
Magentiq Eye's employee count trend
Magentiq Eye has 27 employees as of Apr 26. Here is Magentiq Eye's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Magentiq Eye's Competitors and alternates
Top competitors of Magentiq Eye include Denali Therapeutics, Caris Life Sciences and Personalis. Here is the list of Top 10 competitors of Magentiq Eye, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Denali Therapeutics 2015, San Francisco (United States), Public | Developer of therapies to treat neurodegenerative diseases | $347M | 72/100 | |
2nd | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 71/100 | |
3rd | Personalis 2011, Menlo Park (United States), Public | Provider of genomic sequencing and diagnosis software for the healthcare industry | $87.3M | 70/100 | |
4th | Geneoscopy 2015, St. Louis (United States), Series C | Developer of non-invasive biomarker tests for colorectal cancer | $219M | 67/100 | |
5th | HeartFlow 2007, Redwood City (United States), Public | Provides cardiovascular diagnostic support using analytics | $936M | 67/100 | |
6th | Intellia Therapeutics 2014, Cambridge (United States), Public | Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases | $85M | 66/100 | |
7th | Freenome Health 2014, United States, Series E | Provider of a deep learning platform for detecting circulating cancer-related markers | $1.35B | 66/100 | |
8th | Unilabs 2000, Geneva (Switzerland), Acquired | Provider of diagnostics services company | - | 65/100 | |
9th | ACT Genomics 2014, Taipei (Taiwan), Acquired | Clinical and research services in genomics for cancer | $20.5M | 64/100 | |
10th | Deep Genomics 2014, Toronto (Canada), Series C | AI-powered platform for RNA biology to accelerate genetic therapy discovery | $238M | 63/100 | |
54th | Magentiq Eye 2015, Haifa (Israel), Series A | Computer vision technology in endoscopic procedures | $100K | 55/100 |
Looking for more details on Magentiq Eye's competitors? Click here to see the top ones
Magentiq Eye's Investments and acquisitions
Magentiq Eye has made no investments or acquisitions yet.
News related to Magentiq Eye
Media has covered Magentiq Eye for a total of 4 events in the last 1 year, 3 of them have been about company updates.
•
•
MAGENTIQ EYE Secures Series A Funding Led by aMoon to Advance AI-Powered GastroenterologyPR Newswire•Jul 30, 2025•Namarel Ventures, Norgine, Nina Capital, aMoon and 3 others
•
•
•
•
FDA OKs MAGENTIQ-COLO AI Gastrointestinal Lesion Software DetectionMedical Product Outsourcing•Jul 31, 2023•Magentiq Eye
•
RISE & align: Assuta’s innovation arm to partner with five additional healthtech startupsCTech•Jul 07, 2022•Assuta Centers, Maveriqx, Magentiq Eye, theator and 6 others
Are you a Founder ?
FAQs about Magentiq Eye
Explore our recently published companies
- Austinengineeringcompany - 1937 founded, Unfunded company
- Becsmd - Baltimore based, 2014 founded, Unfunded company
- Capitalcityconstructionllc - United States based, Unfunded company
- Geprolux - Luxembourg based, Funding Raised company
- Daleoffice - United Kingdom based, Unfunded company
- Westructure - United Kingdom based, Unfunded company